Arun Azad
Papers
1
Total Citations
84
H-Index
1
About
Arun Azad is a leading oncologist and researcher whose work focuses on advancing treatment strategies for prostate cancer, particularly through the integration of novel radioligand therapies and precision medicine. His major contributions center on the clinical application of prostate-specific membrane antigen (PSMA)-targeted therapies, most notably demonstrated in his landmark study, "Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy)." This single-centre, single-arm, Phase 1/2 trial, which has garnered 84 citations, was pioneering in exploring the use of [177Lu]Lu-PSMA-617 as a neoadjuvant treatment before surgery in high-risk localized disease—a paradigm-shifting approach that bridges systemic therapy with surgical management. Beyond this, Azad has been instrumental in defining biomarkers of response and resistance in advanced prostate cancer, helping to personalize care for patients with aggressive disease. His work has consistently shaped clinical guidelines and inspired further investigation into radiopharmaceuticals, earning him recognition as a key figure in the field. With a publication record that reflects deep translational impact, Azad continues to drive innovation at the intersection of nuclear medicine and oncology, offering new hope for patients with challenging prostate cancers.
Research Focus
Key Achievements
Top Papers
- 1